BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34609937)

  • 1. Patterns of Failure After Definitive Treatment of T4a Larynx Cancer.
    Voora RS; Panuganti BA; Flagg M; Nelson T; Kotha NV; Qiao EM; Qian AS; Kumar A; Stewart TF; Rose B; Califano J; Weissbrod PA; Mell LK; Orosco RK
    Otolaryngol Head Neck Surg; 2022 Aug; 167(2):274-285. PubMed ID: 34609937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
    Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
    Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pT3 N0 Laryngeal Squamous Cell Carcinoma: Oncologic Outcomes and Prognostic Factors of Surgically Treated Patients.
    Mattioli F; Fermi M; Molinari G; Capriotti V; Melegari G; Bertolini F; D'Angelo E; Tirelli G; Presutti L
    Laryngoscope; 2021 Oct; 131(10):2262-2268. PubMed ID: 33755212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: Sixteen years of experience.
    Vilaseca I; Blanch JL; Berenguer J; Grau JJ; Verger E; Muxí Á; Bernal-Sprekelsen M
    Head Neck; 2016 Jul; 38(7):1050-7. PubMed ID: 26872432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ preservation surgery for patients with T4a laryngeal cancer.
    Zhang C; Zhu M; Chen D; Chen S; Zheng H
    Eur Arch Otorhinolaryngol; 2018 Jun; 275(6):1601-1606. PubMed ID: 29610957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locally advanced hypopharyngeal and laryngeal cancer: Influence of HPV status.
    Bates JE; Morris CG; Hitchcock KE; Dziegielewski PT; Mendenhall WM; Amdur RJ
    Radiother Oncol; 2019 Nov; 140():6-9. PubMed ID: 31174105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy.
    Prabhu RS; Hanasoge S; Magliocca KR; Hall WA; Chen SA; Higgins KA; Saba NF; El-Deiry M; Grist W; Wadsworth JT; Chen AY; Beitler JJ
    Head Neck; 2015 Jun; 37(6):777-82. PubMed ID: 24596123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary organ preservation vs total laryngectomy for T4a larynx cancer.
    Oh J; Prisman E; Olson R; Berthelet E; Wu J; Tran E; Bakos B; Kaviani R; Hamilton SN
    Head Neck; 2019 Sep; 41(9):3265-3275. PubMed ID: 31215719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
    Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
    Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
    Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
    Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
    Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curative-dose Chemoradiotherapy Versus Total Laryngectomy For Stage T3-T4 Squamous Cell Carcinoma of the Larynx: An "Apples-to-Apples" Analysis of the National Cancer Database.
    Bates JE; Amdur RJ; Morris CM; Hitchcock KE; Dziegielewski PT; Boyce BJ; Silver NL; Shaw C; Mendenhall WM
    Am J Clin Oncol; 2019 Jun; 42(6):527-533. PubMed ID: 31136370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor volumetry as a prognostic factor in the management of T4a laryngeal cancer.
    Hsin LJ; Fang TJ; Tsang NM; Chin SC; Yen TC; Li HY; Liao CT; Chen IH
    Laryngoscope; 2014 May; 124(5):1134-40. PubMed ID: 24127228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx.
    Kligerman J; Olivatto LO; Lima RA; Freitas EQ; Soares JR; Dias FL; Melo LE; Sá GM; Duccini E
    Am J Surg; 1995 Nov; 170(5):436-9. PubMed ID: 7485727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).
    Fong PY; Tan SH; Lim DWT; Tan EH; Ng QS; Sommat K; Tan DSW; Ang MK
    PLoS One; 2019; 14(11):e0224665. PubMed ID: 31747406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic Outcomes After Salvage Laryngectomy for Squamous Cell Carcinoma of the Larynx and Hypopharynx: A Multicenter Retrospective Cohort Study.
    Meulemans J; Debacker J; Demarsin H; Vanclooster C; Neyt P; Mennes T; Vauterin T; Huvenne W; Laenen A; Delaere P; Vander Poorten V
    Ann Surg Oncol; 2021 Mar; 28(3):1751-1761. PubMed ID: 32860174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of salvage laryngectomy pathologic and clinical variables to guide further treatment intensification investigation.
    Scharpf J; Ward M; Adelstein D; Koyfman S; Li M
    Laryngoscope; 2018 Apr; 128(4):823-830. PubMed ID: 28891087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Selection for T3/T4a Laryngeal Cancer: Chemoradiation Versus Primary Surgery.
    Timme DW; Jonnalagadda S; Patel R; Rao K; Robbins KT
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):845-51. PubMed ID: 25991835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
    Choi YS; Park SG; Song EK; Cho SH; Park MR; Park KU; Lee KH; Song IC; Lee HJ; Jo DY; Kim S; Yun HJ;
    Head Neck; 2016 Aug; 38(8):1271-7. PubMed ID: 27043228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.